Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
life sciences
national blog main
abbvie
acorda therapeutics
amgen
ampyra
apokyn
apomorphine
biotech
boston blog main
boston top stories
calcitonin gene-related peptide
chronic migraine
dalfampridine
drugs
duopa
eli lilly
episodic migraine
fda
inbrija
indiana
indiana blog main
indiana top stories
migraine
mylan
national top stories
new york
new york blog main
new york top stories
parkinson's disease
paul matteis
stiel
sunovion pharmaceuticals
teva pharmaceutical
the institute for clinical and economic review
What
approved
drug
fda
2
×
late
2
×
new
2
×
acorda
announced
approval
class
cope
decision
developed
disease
eli
episodes
friday
gets
headache
help
lilly
looms
marks
meant
medications
medicines
migraine
nod
pain
parkinson’s
patients
prevent
rival
starts
stop
thursday
treatment
won
working
Language
Current search:
late
×
new
×
fda
×
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
